| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.90M | - | |
| COO | 160.7K | $8.38M | - | |
| CFO | 104.4K | $5.44M | - | |
| Other | 76.0K | $3.96M | - | |
| VP | 29.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 13,669 | $22.73 | $310,721.90 | -1.2% | -6.8% | +13.8% | |
| Aug 19, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 1,331 | $22.40 | $29,809.87 | -0.2% | +23.4% | +28.3% | |
| Aug 16, 2021 | Wright-Mitchell Jane65 | General Counsel | Sale+OE | 2,500 | $26.00 | $65,000.00 | -44.4% | -0.8% | -3.3% | |
| Aug 12, 2021 | Wright-Mitchell Jane65 | General Counsel | Sale+OE | 10,000 | $26.00 | $260,000.00 | -76.2% | -7.5% | -1.1% | |
| Jul 26, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $22.70 | $107,825.00 | -48.0% | +0.2% | +5.0% | |
| Jul 20, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $22.85 | $342,685.50 | -2.5% | +0.1% | +6.5% | |
| Jun 28, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $24.37 | $115,769.84 | -31.3% | +9.1% | -13.2% | |
| Jun 24, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 13,863 | $23.09 | $320,123.31 | -1.2% | +11.1% | -16.7% | |
| Jun 22, 2021 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 1,137 | $22.05 | $25,067.15 | - | +19.9% | -3.7% | |
| Jun 7, 2021 | Fairman Jeff | VP, Research | Sale+OE | 9,500 | $22.50 | $213,750.00 | -64.9% | +12.7% | -13.9% |